Search research articles
Contact Us
Filters
Showing results (91-100 of 471) with videos related to
Page
of 48
Sort By:
JACC. Heart Failure
|
March 7, 2015
Effect of ivabradine on early readmissions after hospitalization for worsening heart failure
Jeffrey S Borer, Michael Böhm, Ian Ford, et al.
International Journal of Cardiology
|
April 24, 2012
Trends in publications on stress-induced cardiomyopathy
Yangzhen Shao, Bjorn Redfors, Alexander R Lyon, et al.
BMJ Open
|
October 9, 2025
Economic evaluation of a person-centred care intervention with a digital platform and structured telephone support for people with chronic heart failure and/or chronic obstructive pulmonary disease: results from a randomised controlled trial in Sweden
Benjamin P Harvey, Emmelie Barenfeld, Andreas Fors, et al.
Lakartidningen
|
May 20, 2006
[BNP or NT-proBNP should be analyzed in suspected heart failure. Guidelines for analysis and interpretation]
Tomas Jernberg, Kurt Boman, Stefan James, et al.
Lakartidningen
|
September 23, 2015
[Stroke prophylaxis in atrial fibrillation: Choose new anticoagulants before warfarin]
Ingmar Torstensson, Carina Blomström-Lundqvist, S Bertil Olsson, et al.
Journal of the American College of Cardiology
|
May 24, 2012
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study
Karl Swedberg, Michel Komajda, Michael Böhm, et al.
Journal of the American College of Cardiology
|
May 20, 2017
Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement?
Ankeet S Bhatt, Adam D DeVore, Tracy A DeWald, et al.
JACC. Heart Failure
|
May 15, 2017
Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the PROFILE Trial After 24 Years
Milton Packer, Bertram Pitt, Jean-Lucien Rouleau, et al.
European Journal of Heart Failure
|
October 7, 2006
International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey
Mitja Lainscak, John G F Cleland, Mattie J Lenzen, et al.
The American Journal of Cardiology
|
December 17, 2013
Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study)
Jeffrey S Borer, Michael Böhm, Ian Ford, et al.
Page
of 48
Search research articles
Search
Showing results (91-100 of 471) with videos related to
Sort By:
Page
of 48
JACC. Heart Failure
|
March 7, 2015
Effect of ivabradine on early readmissions after hospitalization for worsening heart failure
Jeffrey S Borer, Michael Böhm, Ian Ford, et al.
International Journal of Cardiology
|
April 24, 2012
Trends in publications on stress-induced cardiomyopathy
Yangzhen Shao, Bjorn Redfors, Alexander R Lyon, et al.
BMJ Open
|
October 9, 2025
Economic evaluation of a person-centred care intervention with a digital platform and structured telephone support for people with chronic heart failure and/or chronic obstructive pulmonary disease: results from a randomised controlled trial in Sweden
Benjamin P Harvey, Emmelie Barenfeld, Andreas Fors, et al.
Lakartidningen
|
May 20, 2006
[BNP or NT-proBNP should be analyzed in suspected heart failure. Guidelines for analysis and interpretation]
Tomas Jernberg, Kurt Boman, Stefan James, et al.
Lakartidningen
|
September 23, 2015
[Stroke prophylaxis in atrial fibrillation: Choose new anticoagulants before warfarin]
Ingmar Torstensson, Carina Blomström-Lundqvist, S Bertil Olsson, et al.
Journal of the American College of Cardiology
|
May 24, 2012
Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study
Karl Swedberg, Michel Komajda, Michael Böhm, et al.
Journal of the American College of Cardiology
|
May 20, 2017
Achieving a Maximally Tolerated β-Blocker Dose in Heart Failure Patients: Is There Room for Improvement?
Ankeet S Bhatt, Adam D DeVore, Tracy A DeWald, et al.
JACC. Heart Failure
|
May 15, 2017
Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the PROFILE Trial After 24 Years
Milton Packer, Bertram Pitt, Jean-Lucien Rouleau, et al.
European Journal of Heart Failure
|
October 7, 2006
International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey
Mitja Lainscak, John G F Cleland, Mattie J Lenzen, et al.
The American Journal of Cardiology
|
December 17, 2013
Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (from the SHIFT study)
Jeffrey S Borer, Michael Böhm, Ian Ford, et al.
Page
of 48